Abstract

Should we broaden indications for anti-JCV antibody tests in multiple sclerosis patients? No

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Lymphocyte calcium influx characteristics and its modulation by Kv1.3 and IKCa1 potassium channel inhibitors in multiple sclerosis
...
F1000Research | VOL. 2
, et. al. ...
06 Jul 2011
Characteristics of COVID-19 disease in multiple sclerosis patients
Vahid Shaygannejad ... Mahdi Barzegar
Multiple Sclerosis and Related Disorders | VOL. 45
Vahid Shaygannejad, et. al.Vahid Shaygannejad ... Mahdi Barzegar
08 Jun 2020
New treatments and azathioprine in multiple sclerosis
Oldrich J Kolar
The Lancet | VOL. 350
Oldrich J KolarOldrich J Kolar
01 Oct 1997
COVID-19 in multiple sclerosis and neuromyelitis optica spectrum disorder patients in Latin America: COVID-19 in MS and NMOSD patients in LATAM
Liesbet M Peeters ...
Multiple Sclerosis and Related Disorders | VOL. 51
Liesbet M Peeters, et. al.Liesbet M Peeters ...
07 Mar 2021
View more papers

More From: Revue Neurologique

Paper Title
Journal
Date
Author
French guidelines for the diagnosis and management of Tourette syndrome
Andreas Hartmann ... Mathieu Anheim
Revue Neurologique | VOL. -
Andreas Hartmann, et. al.Andreas Hartmann ... Mathieu Anheim
16 May 2024
Metabolic syndrome and the phenotype of multiple sclerosis
H Gauthier ... A Créange
Revue Neurologique | VOL. -
H Gauthier, et. al.H Gauthier ... A Créange
01 May 2024
Development of an Objective Structured Clinical Examination (OSCE) to evaluate the diagnosis announcement of chronic neurological disease by residents in neurology
D Maltete ... B Bourre
Revue Neurologique | VOL. -
D Maltete, et. al.D Maltete ... B Bourre
01 May 2024
Contents
-
Revue Neurologique | VOL. 180
--
01 May 2024
View more papers